Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection
This study has been completed.
Sponsor:
Achillion Pharmaceuticals
Information provided by:
Achillion Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00034359
First received: April 26, 2002
Last updated: July 20, 2006
Last verified: September 2002
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |